OMER News and Press, Omeros Corporation From 10/03/23

2023-10-03 17:29:36 ET Gainers: Edgewise Therapeutics ( NASDAQ: EWTX ) +7% . Cantaloupe ( CTLP ) +6% . Computer Programs and Systems ( CPSI ) +6% . REGENXBIO  ( RGNX ) +5% . Tandem Diabetes Care ( TNDM ) +5% . Lose...

2023-09-20 11:55:57 ET More on Health Care Sector: Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecutiv...

2023-09-15 16:49:26 ET Gainers: Omeros Corporation ( NASDAQ: OMER ) +5% . The Lovesac Company ( LOVE ) +4% . Patriot Transportation  ( PATI ) +3% . Cipher Mining ( CIFR ) +2% . Humacyte ( HUMA ) +2% . Losers: San...

2023-08-24 08:00:00 ET Summary Omeros focuses on immunologic disorders; faces FDA approval challenges for lead drug narsoplimab. Q2 2023 reports net loss of $37.3M; significant debt and rising expenses threaten financial stability. Investment recommendation: "Sell" due to fina...

2023-08-23 07:30:49 ET Summary Omeros' "Buy" stance is based on upcoming developments in the second half of 2023-2024 around narsoplimab. OMER is expected to present a detailed analysis strategy for the narsoplimab BLA's reapplication for HSCT-TMA, leading to a potential PDUFA by ...

2023-08-09 13:28:16 ET Omeros Corporation (OMER) Q2 2023 Earnings Conference Call August 09, 2023, 08:30 ET Company Participants Jennifer Williams - IR Gregory Demopulos - Co-Founder, Chairman, CEO & President Michael Jacobsen - CAO, VP, Finance & Treasur...

2023-08-09 08:04:18 ET Omeros press release ( NASDAQ: OMER ): Q2 GAAP EPS of -$0.70 misses by $0.13 . Cash burn for the quarter ended June 30, 2023 was $30.1 million, an amount artificially inflated by $3.4 million corresponding to Rayner’s late payment of royal...

– Conference Call Today at 8:30 a.m. ET – Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immuno...

2023-08-08 12:43:26 ET Omeros ( NASDAQ: OMER ) is scheduled to announce Q2 earnings results on Wednesday, August 9th, before market open. The consensus EPS Estimate is -$0.53 and the consensus Revenue Estimate is $0M. Over the last 1 year, OMER has beaten EPS estimat...

2023-08-08 10:46:10 ET Major earnings expected before the bell on Wednesday include: Brookfield Asset Management ( BAM ) 3D Systems ( DDD ) PENN Entertainment ( PENN ) Roblox ( RBLX ) Sony Group ( SONY ) For further details see: Notable ea...